Delivery Order SPE2DB22D1002-SPE2DB25FKZH0
Award Date 3/12/25
Potential Completion Date 3/13/25
Potential Value $4.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract is a firm fixed-price delivery order with a ceiling value of $2,013.21 and a period of performance through July 2, 2025. It is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 90S. The contract has a ceiling value of $4,587.85 and an ultimate completion date of August 5, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $7,891.35 and a completion date of June 9, 2025. It is a firm fixed-price contract, indicating that the price is pre-determined. The contract is not set-aside, meaning it was open to full and open competition. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 30S, a medication, with a firm fixed price ceiling value of $1,297.05 and a period of performance through June 24, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $1,797.26 and is a firm fixed-price contract with a period of performance through May 2, 2025. The contract is not set-aside and was openly competed. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $2,376.00 and is a firm fixed price, non-set-aside contract with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a firm fixed price of $4,751.70 and a completion date of June 12, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a medical product, with a ceiling value of $17,397.00 and a completion date of November 14, 2024. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $4,659.98, is for the delivery of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025 and is a firm fixed-price type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $86,501.38, is for the supply of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has a period of performance through February 12, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...